An alfacalcidol soft capsule composition and a method for preparing the same
By combining alfacalcidol eutectic with an oily matrix and using gelatin and compound plasticizers as the soft capsule shell material, the problems of shell aging and delayed dissolution of alfacalcidol soft capsules during long-term storage have been solved, achieving improved stability and solubility, making it suitable for industrial production.
Patent Information
- Application Number
- CN202511106884.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-08-08
- Publication Date
- 2026-03-17
- Estimated Expiration
- 2045-08-08
AI Technical Summary
Existing alfacalcidol soft capsules suffer from disintegration and delayed dissolution due to cross-linking and aging of the capsule shell during long-term storage, which affects the efficacy of the drug. Furthermore, existing technologies have not been able to effectively solve this problem.
Alfacalcidol eutectic is combined with an oily matrix, and gelatin and plasticizer (a combination of glycerol, erythritol and glycine) are used as the shell material. A stable eutectic structure is formed through hydrogen bonds and non-covalent bonds, which enhances the barrier properties and antioxidant properties of the shell and inhibits the aging of the shell.
It improves the stability and solubility of alfacalcidol soft capsules, delays shell aging, ensures long-term stability of efficacy and dissolution rate, and is suitable for industrial production.